ACCEL-SEVELAMER
Identification of Accel-Sevelamer
| No description |
Google image searchProduct monograph
Active ingredient
sevelamer carbonate, 800 MG
DIN: 02461501
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: ACCEL PHARMA INC
Date: 08-NOV-2017
ATC:
- V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
- V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
- V03AE — Drugs for treatment of hyperkalemia and hyperphosphatemia (ATC, ATC/DDD)
- V03AE02 — SEVELAMER (ATC/DDD)
Reference brand drug: Renagel, Renvela
Pharmaceutical standard: USP
